Physician profile
Emily Burnham
NPI 1821547290
$5,906.24
in general payments reported to CMS, 2019-2025
14 companies · $2,262 in 2025
The $2,262 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.60 · 2023: $3,047 · 2024: $581 · 2025: $2,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,328 · Food and Beverage: $2,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,327.54 |
| Food and Beverage | $2,563.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,049.52 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Relievant Medsystems, INC. | $789.80 | 2023 | Intracept |
| Mml US, INC. | $247.01 | 2025 | Reactiv8 |
| Abbvie INC. | $221.65 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $183.49 | 2022-2025 | Xtampza, Belbuca |
| Vertex Pharmaceuticals Incorporated | $155.23 | 2024-2025 | |
| Spr Therapeutics, INC | $72.79 | 2024-2025 | Sprint Pns System |
| Pfizer INC. | $45.90 | 2023-2024 | |
| Abbott Laboratories | $34.46 | 2023 | Proclaim |
| Ipsen Biopharmaceuticals, INC | $26.34 | 2024 | Dysport |
| Avanos Medical | $25.77 | 2025 | |
| Stryker Corporation | $20.30 | 2025 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $19.95 | 2023 | Ztlido |
| Fidia Pharma USA INC. | $14.03 | 2023 | Hymovis, Triluron |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Burnham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.